© 1994 by Oxford University Press
Journal of the National Cancer Institute, Vol. 86, No. 9, 705-712,
May 4, 1994
© 1994 Oxford University Press
Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States1
*The University of Texas Health Science Center, Division of Medical Oncology San Antonio, Tex
Correspondence to: Richard M. Elledge. M.D., The University of Texas Health Science Center, Division of Medical Oncology, 7703 Floyd Curl Dr., San Antonio, TX 78284–7884.
BACKGROUND:: In the United States, prognosis and survival after the diagnosis of breast cancer is poorer among black patients and, to a lesser extent, among Hispanic patients, compared with white patients. Patients who are black or Hispanic have been reported to present with higher stage or more advanced disease. Even after adjusting for stage, however, survival rates are lower for blacks but not for Hispanics. Purpose: Our purpose was to compare survival, age, tumor size, nodal status, estrogen-receptor (ER) and progesterone-receptor (PgR) status, histologic type, S-phase fraction, DNA ploidy status, HER-2/neu protein expression, and p53 protein status, along with systemic treatment, in a large group of white, black, and Hispanic U.S. women. Methods: From 1970 to 1991, breast tumor specimens were submitted to The University of Texas Health Science Center from 31 contributing hospitals throughout the United States for ER and PgR assay. A total of 4885 white, 1016 black, and 777 Hispanic women were eligible for this study. Median follow-up was 57 months. Results: Overall, white women were significantly more likely to be older and to have smaller tumors, have less lymph node involvement, have tumors with positive ER and PgR status, and have a lower S-phase fraction compared with Hispanic or black women. There were no clinically important differences in DNA ploidy, histologic type, HER-2/neu, and p53 expression among the three groups. Considering all stages, white women had the best overall survival (date of diagnosis to date of death) at 5 years–75% ±1% (means ± SE), with a median survival of 166 months, but Hispanic women had an intermediate survival—70% ± 2% (median survival, 156 months), and black women had the worst survival—65% ± 2% (median survival, 117 months) (P<.0001). For node-negative patients, there was no significant difference in disease-free survival (date of diagnosis to date of first recurrence) or overall survival, although blacks tended to have a worse prognosis. For node-positive or locally advanced disease and for metastatic disease, blacks had significantly (P<.0001) worse disease-free and overall survival than did white or Hispanic women. Differences in the use of systemic therapy did not explain these outcomes. Conclusion: A number of biologic factors associated with poor prognosis are found with a significantly increased frequency in breast tumors from Hispanic and, particularly, from black women. Tumors with a more aggressive biology could lead to a higher stage at diagnosis and a poorer survival for the group as a whole. [J Natl Cancer Inst 86: 705–712, 1994]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Vona-Davis, D. P. Rose, H. Hazard, M. Howard-McNatt, F. Adkins, J. Partin, and G. Hobbs Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3319 - 3324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Marti, A. Guth, A. Naik, and K. L. Hiotis Receptor Status and Ethnicity of Indigent Patients With Breast Cancer in New York City Arch Surg, December 1, 2008; 143(12): 1227 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dawood, K. Broglio, A. M. Gonzalez-Angulo, A. U. Buzdar, G. N. Hortobagyi, and S. H. Giordano Trends in Survival Over the Past Two Decades Among White and Black Patients With Newly Diagnosed Stage IV Breast Cancer J. Clin. Oncol., October 20, 2008; 26(30): 4891 - 4898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Hines, B. Risendal, M. L. Slattery, K. B. Baumgartner, A. R. Giuliano, and T. Byers Differences in Estrogen Receptor Subtype According to Family History of Breast Cancer among Hispanic, but not Non-Hispanic White Women Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2700 - 2706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Smith, S. A. Adams, I. P. Das, M. Bottai, J. Fulton, and J. R. Hebert Breast Cancer Survival among Economically Disadvantaged Women: The Influences of Delayed Diagnosis and Treatment on Mortality Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2882 - 2890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Polite, C. Cirrincione, G. F. Fleming, D. A. Berry, A. Seidman, H. Muss, L. Norton, C. Shapiro, K. Bakri, K. Marcom, et al. Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B J. Clin. Oncol., June 1, 2008; 26(16): 2659 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. E. Hahn, M. L. Bondy, M. Selvan, M. J. Lund, J. M. Liff, E. W. Flagg, L. A. Brinton, P. Porter, J. W. Eley, and R. J. Coates Factors Associated with Advanced Disease Stage at Diagnosis in a Population-based Study of Patients with Newly Diagnosed Breast Cancer Am. J. Epidemiol., November 1, 2007; 166(9): 1035 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Crew, A. I. Neugut, X. Wang, J. S. Jacobson, V. R. Grann, G. Raptis, and D. L. Hershman Racial Disparities in Treatment and Survival of Male Breast Cancer J. Clin. Oncol., March 20, 2007; 25(9): 1089 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Moy, D Tu, J. Pater, J. Ingle, L. Shepherd, T. Whelan, and P. Goss Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer Ann. Onc., November 1, 2006; 17(11): 1637 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mandelblatt, C. B. Schechter, W. Lawrence, B. Yi, and J. Cullen Chapter 8: The SPECTRUM Population Model of the Impact of Screening and Treatment on U.S. Breast Cancer Trends From 1975 to 2000: Principles and Practice of the Model Methods J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kimmick, F. Camacho, K. L. Foley, E. A. Levine, R. Balkrishnan, and R. Anderson Racial Differences in Patterns of Care Among Medicaid-Enrolled Patients With Breast Cancer J. Oncol. Pract, September 1, 2006; 2(5): 205 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Amend, D. Hicks, and C. B. Ambrosone Breast Cancer in African-American Women: Differences in Tumor Biology from European-American Women. Cancer Res., September 1, 2006; 66(17): 8327 - 8330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Smith-Bindman, D. L. Miglioretti, N. Lurie, L. Abraham, R. B. Barbash, J. Strzelczyk, M. Dignan, W. E. Barlow, C. M. Beasley, and K. Kerlikowske Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med, April 18, 2006; 144(8): 541 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Richardson, L. Tian, L. Voti, A. G. Hartzema, I. Reis, L. E. Fleming, and J. MacKinnon The Roles of Teaching Hospitals, Insurance Status, and Race/Ethnicity in Receipt of Adjuvant Therapy for Regional-Stage Breast Cancer in Florida Am J Public Health, January 1, 2006; 96(1): 160 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W F Symmans, D J Fiterman, S K Anderson, M Ayers, R Rouzier, V Dunmire, J Stec, V Valero, N Sneige, C Albarracin, et al. A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding Endocr. Relat. Cancer, December 1, 2005; 12(4): 1059 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Katz, P. M. Lantz, Y. Paredes, N. K. Janz, A. Fagerlin, L. Liu, and D. Deapen Breast Cancer Treatment Experiences of Latinas in Los Angeles County Am J Public Health, December 1, 2005; 95(12): 2225 - 2230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Jatoi, W. F. Anderson, S. R. Rao, and S. S. Devesa Breast Cancer Trends Among Black and White Women in the United States J. Clin. Oncol., November 1, 2005; 23(31): 7836 - 7841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hershman, R. McBride, J. S. Jacobson, L. Lamerato, K. Roberts, V. R. Grann, and A. I. Neugut Racial Disparities in Treatment and Survival Among Women With Early-Stage Breast Cancer J. Clin. Oncol., September 20, 2005; 23(27): 6639 - 6646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Newman Breast Cancer in African-American Women Oncologist, January 1, 2005; 10(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Baumgartner, W. C. Hunt, R. N. Baumgartner, D. D. Crumley, F. D. Gilliland, A. McTiernan, L. Bernstein, and R. Ballard-Barbash Association of Body Composition and Weight History with Breast Cancer Prognostic Markers: Divergent Pattern for Hispanic and Non-Hispanic White Women Am. J. Epidemiol., December 1, 2004; 160(11): 1087 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cianfrocca and L. J. Goldstein Prognostic and Predictive Factors in Early-Stage Breast Cancer Oncologist, November 1, 2004; 9(6): 606 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Mandelblatt, C. B. Schechter, K. R. Yabroff, W. Lawrence, J. Dignam, P. Muennig, Y. Chavez, J. Cullen, and M. Fahs Benefits and Costs of Interventions to Improve Breast Cancer Outcomes in African American Women J. Clin. Oncol., July 1, 2004; 22(13): 2554 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mandelblatt, S. Saha, S. Teutsch, T. Hoerger, A. L. Siu, D. Atkins, J. Klein, M. Helfand, and for the Cost Work Group of the U.S. Preventive Ser The Cost-Effectiveness of Screening Mammography beyond Age 65 Years: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med, November 18, 2003; 139(10): 835 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hershman, M. Weinberg, Z. Rosner, K. Alexis, A. Tiersten, V. R. Grann, A. Troxel, and A. I. Neugut Ethnic Neutropenia and Treatment Delay in African American Women Undergoing Chemotherapy for Early-Stage Breast Cancer J Natl Cancer Inst, October 15, 2003; 95(20): 1545 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Selvin and K. M. Brett Breast and Cervical Cancer Screening: Sociodemographic Predictors Among White, Black, and Hispanic Women Am J Public Health, April 1, 2003; 93(4): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. I. Li, K. E. Malone, and J. R. Daling Differences in Breast Cancer Stage, Treatment, and Survival by Race and Ethnicity Arch Intern Med, January 13, 2003; 163(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Li, K. E. Malone, and J. R. Daling Differences in Breast Cancer Hormone Receptor Status and Histology by Race and Ethnicity among Women 50 Years of Age and Older Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 601 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jacobellis and G. Cutter Mammography Screening and Differences in Stage of Disease by Race/Ethnicity Am J Public Health, July 1, 2002; 92(7): 1144 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Marchbanks, J. A. McDonald, H. G. Wilson, S. G. Folger, M. G. Mandel, J. R. Daling, L. Bernstein, K. E. Malone, G. Ursin, B. L. Strom, et al. Oral Contraceptives and the Risk of Breast Cancer N. Engl. J. Med., June 27, 2002; 346(26): 2025 - 2032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Brawley Disaggregating the Effects of Race and Poverty on Breast Cancer Outcomes J Natl Cancer Inst, April 3, 2002; 94(7): 471 - 473. [Full Text] [PDF]
|
|
|
|
|
|
B. A. Miller, B. F. Hankey, and T. L. Thomas Impact of Sociodemographic Factors, Hormone Receptor Status, and Tumor Grade on Ethnic Differences in Tumor Stage and Size for Breast Cancer in US Women Am. J. Epidemiol., March 15, 2002; 155(6): 534 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. Shavers and M. L. Brown Racial and Ethnic Disparities in the Receipt of Cancer Treatment J Natl Cancer Inst, March 6, 2002; 94(5): 334 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Dignam Efficacy of Systemic Adjuvant Therapy for Breast Cancer in African-American and Caucasian Women J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 36 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Muss Factors Used to Select Adjuvant Therapy of Breast Cancer in the United States: an Overview of Age, Race, and Socioeconomic Status J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 52 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Moorman, B. A. Jones, R. C. Millikan, I. J. Hall, and B. Newman Race, Anthropometric Factors, and Stage at Diagnosis of Breast Cancer Am. J. Epidemiol., February 1, 2001; 153(3): 284 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Chu, R. E. Tarone, and O. W. Brawley Breast Cancer Trends of Black Women Compared With White Women Arch Fam Med, November 1, 1999; 8(6): 521 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. U. Yood, C. C. Johnson, A. Blount, J. Abrams, E. Wolman, B. D. McCarthy, U. Raju, D. S. Nathanson, M. Worsham, and S. R. Wolman Race and Differences in Breast Cancer Survival in a Managed Care Population J Natl Cancer Inst, September 1, 1999; 91(17): 1487 - 1491. [Abstract] [Full Text] [PDF]
|
|